valine and tramiprosate

valine has been researched along with tramiprosate in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abushakra, S; Amedio, J; Hey, JA; Kaplan, PL; Kocis, P; Power, A; Tolar, M; Versavel, M; Yu, JY	1
Abushakra, S; Hey, JA; Hort, J; Kocis, P; Power, A; Tolar, M; Vyhnálek, M; Yu, JY	1

Trials

2 trial(s) available for valine and tramiprosate

Article	Year
Clinical Pharmacokinetics and Safety of ALZ-801, a Novel Prodrug of Tramiprosate in Development for the Treatment of Alzheimer's Disease. Clinical pharmacokinetics, 2018, Volume: 57, Issue:3 Topics: Administration, Oral; Adult; Aged; Alzheimer Disease; Area Under Curve; Capsules; Dose-Response Relationship, Drug; Double-Blind Method; Female; Half-Life; Humans; Male; Middle Aged; Prodrugs; Tablets; Taurine; Valine; Young Adult	2018
Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain. CNS drugs, 2018, Volume: 32, Issue:9 Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Chromatography, Liquid; Cognition Disorders; Computer Simulation; Drug Administration Routes; Female; Humans; Male; Mental Status Schedule; Middle Aged; Models, Chemical; Nonlinear Dynamics; Peptide Fragments; Prodrugs; Propionates; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Taurine; Valine	2018

Article

Year

Clinical Pharmacokinetics and Safety of ALZ-801, a Novel Prodrug of Tramiprosate in Development for the Treatment of Alzheimer's Disease.

Clinical pharmacokinetics, 2018, Volume: 57, Issue:3

Topics: Administration, Oral; Adult; Aged; Alzheimer Disease; Area Under Curve; Capsules; Dose-Response Relationship, Drug; Double-Blind Method; Female; Half-Life; Humans; Male; Middle Aged; Prodrugs; Tablets; Taurine; Valine; Young Adult

2018

Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain.

CNS drugs, 2018, Volume: 32, Issue:9

Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Chromatography, Liquid; Cognition Disorders; Computer Simulation; Drug Administration Routes; Female; Humans; Male; Mental Status Schedule; Middle Aged; Models, Chemical; Nonlinear Dynamics; Peptide Fragments; Prodrugs; Propionates; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Taurine; Valine

2018